The transformation of proto-oncogenes such as RAS, RAF, MEK, ERK, and AKT to oncogenes due to chemical, physical, or genetic mutations stimulates the cell proliferation in early cancer by activating the signaling pathways of the unbridled cell proliferation, and by inactivating the signaling pathways of the apoptosis suppression [201]. This evidence concerns the gene MAP2K7 and cancer.